Comment by
rad10 on Nov 18, 2015 1:20pm
Not really. Valeant's problems are unique to valeant. Loss of key employees at Valeant may be beneficial to the sector as a whole - but valeant does very little R and D. Key employees are not the high powered scientists that are difficult or impossible to replace. Long CXR, short VRX for the time being